홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
AYTU
#3661
AYTU BioPharma, Inc. Common Stock
2.5
7
+3.21%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+3.21%
월간 변동
-3.02%
6달 변화
+7.98%
년간 변동율
+102.36%
이전 종가
2.4
9
Open
2.5
7
Bid
Ask
Low
2.5
7
High
2.5
7
양
1
마켓
주식
헬스케어
AYTU
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
TTM
Key stats
Total common shares outstanding
6.17 M
9.91 M
10.19 M
10.73 M
—
Valuation ratios
Enterprise value
-10.77 M
-9.34 M
-13.48 M
-2.12 M
-35.71 M
Price to earnings ratio
1.89
1.01
1.82
10.68
15.4
Price to sales ratio
0.1
0.21
0.26
0.38
0.95
Price to cash flow ratio
2.04
7.07
117.87
13.19
140.17
Price to book ratio
0.07
0.72
0.16
0.26
1.21
Enterprise value to EBITDA ratio
28.12
3.69
-4.3
0.99
28.5
Profitability ratios
Return on assets %
0.03
0.06
0.02
0.09
0.19
Return on equity %
0.11
0.39
0.08
0.75
1.33
Return on invested capital %
16.63
18.19
10.02
13.39
58.22
Gross margin %
69.4
67.75
66.14
63.46
266.76
Operating margin %
13.12
18.37
10.83
12.99
55.32
EBITDA margin %
18.79
-26.52
-4.35
-6.52
-18.6
Net margin %
21.65
48.27
14.15
69.79
153.86
Liquidity ratios
Quick ratio
0.87
1.07
1.08
1.03
4.05
Current ratio
1.03
1.26
1.23
1.16
4.67
Inventory turnover
0.51
0.43
0.44
0.59
1.97
Asset turnover
0.15
0.12
0.11
0.12
0.51
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0.08
0.09
0.08
0.08
0.33
Long term debt to total equity ratio
0.27
0.57
0.45
0.7
2
Per share metrics
Operating cash flow per share
0.37
-0.45
0.03
0.24
0.2
EBIT per share
0.3
-1.21
-0.08
-0.2
-1.19
EBITDA per share
0.42
-0.64
-0.03
-0.1
-0.35
Total debt per share
—
—
—
—
—
Cash per share
2.22
4.93
1.68
2.99
11.81
Net current asset value per share
8.84
12.61
4.16
7.6
33.21
Tangible book value per share
-1.68
-3.7
-0.94
-2.93
-9.25
Working capital per share
0.22
2.57
0.78
1.06
4.63
Book value per share
4.25
3.02
1.19
1.41
9.88
뉴스
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
Aytu BioPharma 2분기 매출 감소, 주가 하락
Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls
New Strong Sell Stocks for February 2nd
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20
Aytu launches EXXUA, first selective 5-HT1A agonist for depression
Aytu BioPharma, 우울증 치료제 EXXUA 출시 후 주가 상승
Aytu BioPharma stock rises after commercial launch of depression drug EXXUA
Aytu BioPharma, 우울증 치료제 EXXUA 미국 시장 출시
Aytu BioPharma launches depression drug EXXUA in U.S. market